A Study of LY4088044 in Healthy Participants

NCT07090785 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY4088044
DRUG: LY4088044
DRUG: Placebo
DRUG: Placebo

Sponsor

Eli Lilly and Company